Endowment / Foundation

Updated:

The Jackson Laboratory

The Jackson Laboratory's mission is to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to...

The Jackson Laboratory logo

The Jackson Laboratory

The Jackson Laboratory's mission is to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health.

General information

Firm type

Endowment / Foundation

Year founded

1929

Location

Region

North America

Country

United States

City

Bar Harbor

Corporate office

600 Main St, Bar Harbor, ME 04609, United States

Additional offices

Farmington, CT · Sacramento, CA · Ellsworth, ME · Gainesville, FL · Atsugi, Japan · Yokohama, Japan

Principals

Lon Cardon

President and CEO

Mary Kate Wold

Trustee and Chair of the Investment Committee

Geoffrey W. Smith

Trustee and Chair of the Finance & Investment Committee

Neal Milch

Chair of the Board of Trustees

Sector focus

Healthcare ServicesReal Estate

Frequently asked questions

How is The Jackson Laboratory funded beyond its endowment?

JAX operates on a diversified non-profit revenue model. The largest sources are National Institutes of Health research grants and the JAX Mice & Services business, which supplies genetically standardized mouse models to laboratories globally. Philanthropic gifts, including endowed chairs like the Bernard and Lusia Milch Endowed Chair, supplement these operating revenues. The endowment provides a long-term financial cushion but is not the sole lifeblood of the institution.

What is JAX's relationship with the drug development industry?

JAX occupies a position upstream of pharmaceutical R&D. Its mouse models are the standard substrate for preclinical drug testing across oncology, immunology, and rare disease research. In 2024, JAX deepened its translational footprint by initiating a drug-candidate identification collaboration with Unravel Biosciences, directly applying its genomic data resources to therapy development rather than solely supplying research tools.

Who are JAX's governance leaders as of early 2025?

Neal Milch was elected Chair of the Board of Trustees in early 2025. Mary Kate Wold serves as Trustee and Chair of the Investment Committee. Geoffrey W. Smith serves as Trustee and Chair of the Finance & Investment Committee. President and CEO Lon Cardon holds the senior executive position, overseeing day-to-day strategy and operations for all JAX campuses.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on endowments & foundations?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Bar Harbor Endowment / Foundation profiles